Glaucoma

Top Story

Timolol use increases due to rise of combination therapies for glaucoma

February 17, 2017

Fixed combination glaucoma therapies have led to an increase in the use of nonselective -blockers, which may negatively impact patient safety, especially in older patients and should be studied further, researchers said.

The number of fixed-dose combination therapies for glaucoma has grown in recent years, and only the nonselective -blocker timolol is used in the -blocker function, according to researchers. However, ophthalmic timolol has been associated with severe systemic adverse events and include numerous cases resulting in death, researchers said.

Perspectives on Glaucoma

OCT imaging of retina useful in detecting glaucoma ‘masqueraders’

February 16, 2017
Optic nerve and macular optical coherence tomography can be helpful in distinguishing between glaucoma and glaucoma masqueraders, according to researchers. Researchers…
Perspectives on Glaucoma

Oral acetazolamide reduces IOP elevation during, after cataract surgery

February 16, 2017
Oral acetazolamide given 1 hour prior to cataract surgery in eyes with glaucoma significantly reduces the IOP elevation from 1 to 24 hours, while administering the drug…
Perspectives on Glaucoma

Nocturnal blood pressure ‘overdippers’ have higher risk for ODH in normal-tension glaucoma

February 15, 2017
A “nonphysiologic” nocturnal blood pressure dip is a risk factor for the occurrence of optic disc hemorrhage in patients with normal-tension glaucoma…
CME

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to…
More »
Video
Meeting News

VIDEO: MIGS restores natural outflow through trabecular meshwork

January 18, 2017
More »
Featured
Video
Meeting News

VIDEO: Speaker: Stab incision trabeculectomy reduces surgery time

February 3, 2017
More »
Perspectives on Glaucoma

Timolol use increases due to rise of combination therapies for glaucoma

February 17, 2017
Fixed combination glaucoma therapies have led to an increase in the use of nonselective -blockers, which may negatively impact patient safety…

Perspectives on Glaucoma

OCT imaging of retina useful in detecting glaucoma ‘masqueraders’

February 16, 2017
Optic nerve and macular optical coherence tomography can be helpful in distinguishing between glaucoma and glaucoma masqueraders, according to…

Perspectives on Glaucoma

Oral acetazolamide reduces IOP elevation during, after cataract surgery

February 16, 2017
Oral acetazolamide given 1 hour prior to cataract surgery in eyes with glaucoma significantly reduces the IOP elevation from 1 to 24 hours, while…

Perspectives on Glaucoma

Nocturnal blood pressure ‘overdippers’ have higher risk for ODH in normal-tension glaucoma

February 15, 2017
A “nonphysiologic” nocturnal blood pressure dip is a risk factor for the occurrence of optic disc hemorrhage in patients with…

BLOG: When costly drugs are standard of care

February 10, 2017
Let’s say you’re going to the hardware store to buy a wrench. Naturally, the store sells more than one product that can do the same job…

Proposed N.C. legislation expands scope of practice to include certain laser procedures

February 8, 2017
The Enact Enhanced Access to Eye Care Act, amending the scope of practice in optometry allowing for certain laser and surgical procedures in North…

Meeting News

Industry leaders give hazy outlook for changing political climate

February 8, 2017
SAN FRANCISCO — Corporate leaders are at the same time optimistic and worried about the changing political environment and its impact on the…

Meeting News

Good manufacturing pathway needed for FDA to consider new drug approvals

February 7, 2017
SAN FRANCISCO — Six ophthalmic new drug applications were stalled by the FDA in 2016 for issues with chemistry, manufacturing and controls…

Meeting News

Venture capitalists look for market, path to reimbursement

February 6, 2017
SAN FRANCISCO — Clear identification of a market and a path for reimbursement are two necessary ingredients for venture capitalists in the…

Meeting News

Wearable technology in future for glaucoma patients

February 6, 2017
SAN FRANCISCO — Wearable technology will empower glaucoma patients as telemedicine opportunities are advanced, according to Louis R. Pasquale

More Headlines »
Advertisement
Advertisement